AMRI has promoted Takeshi Yura to Vice President of Discovery and Development Services, Asia.
Yura joined AMRI in January 2011 and was most recently Senior Director of Drug Discovery services in Singapore, leading the chemistry and biology teams of AMRI's flagship Asian integrated drug discovery operations.
In his new role, Yura will also take leadership of AMRI’s Discovery and Development efforts at its Hyderabad, India site.
AMRI’s Chairman, President and CEO Thomas D’Ambra said: ‘AMRI’s Singapore and Hyderabad operations are important and growing businesses for AMRI and conduct projects for customers located all over the world. We believe that Dr Yura’s leadership, his focus on excellence in scientific research and his dedication to quality and the integrity of our customers’ intellectual property will provide integration under one leadership of what we are referring to as AMRI Asia.’
Yura has more than 22 years of scientific and leadership experience in discovery research, project management and business development. Before joining AMRI, he was a Director at Dishman Japan, responsible for sales and all business development activities for contract manufacturing services. Before that, he was Discovery Chemistry Research Head at Pfizer Japan, dedicated primarily to the areas of pain and gastrointestinal drug discovery. Prior to Pfizer, he was Section Head, Medicinal Chemistry at Bayer Yakuhin in Japan focused on urology and asthma. He has held additional scientific roles at Ciba Geigy Japan and Tanabe Seiyaku.
